0001950047-24-002567.txt : 20240320
0001950047-24-002567.hdr.sgml : 20240320
20240320162259
ACCESSION NUMBER: 0001950047-24-002567
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240320
DATE AS OF CHANGE: 20240320
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 24768075
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: AFEYAN NOUBAR
CENTRAL INDEX KEY: 0001222012
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O FLAGSHIP PIONEERING, INC.
STREET 2: 55 CAMBRIDGE PARKWAY, SUITE 800E
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
144
1
primary_doc.xml
144
0001222012
XXXXXXXX
LIVE
0001682852
Moderna, Inc.
001-38753
200 Technology Square
Cambridge
MA
02139
6177146700
NOUBAR B AFEYAN
Director
COMMON
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
15000
1576650.00
382073208
03/20/2024
NASDAQ
Common
06/21/2012
Private Placement
Issuer
N
15000
06/21/2012
Cash
N
10b5-1 Sales Plan for NOUBAR B AFEYAN
200 Technology Square
Cambridge
MA
02139
Common
03/13/2024
15000
1628031.00
03/20/2024
11/07/2023
/s/ Noubar B. Afeyan